CD4+ T cell receptor recognizing carrier protein-derived peptides presented on MHC class II (CD4+ TCR (MHC II-restricted))

The CD4+ T cell receptor (TCR) recognizing carrier protein-derived peptides presented on MHC class II is a fundamental mediator of the adaptive immune response, specifically facilitating T-cell-dependent antibody production (Avci et al., 2011). These receptors are typically alpha-beta heterodimers that recognize specific peptide fragments derived from carrier proteins, such as CRM197 or tetanus toxoid, which have been processed and displayed by Major Histocompatibility Complex (MHC) class II molecules (Pichichero, 2013). This recognition event triggers a signaling cascade through the CD3 complex, leading to the activation and differentiation of CD4+ helper T cells (Janeway et al., 2001). These activated T cells then provide essential signals to B cells, enabling isotype switching and the formation of high-affinity memory B cells, a process central to the efficacy of conjugate vaccines (Pollard et al., 2009). Beyond vaccinology, these TCRs play roles in autoimmune diseases where they may inappropriately recognize self-peptides presented on MHC II, and in allergic responses to foreign proteins (Kwok et al., 2001). Targeting or modulating these receptors is a key strategy in developing vaccines against encapsulated bacteria and in treating immune-mediated inflammatory diseases (Lanzavecchia, 1985).

Other names

MHC class II-restricted T cell receptorCarrier-specific CD4+ T cell receptorTCR-CD3 complexAntigen-specific T cell receptor

The TCR alpha/beta heterodimer binds to a specific peptide-MHC class II complex on an antigen-presenting cell, initiating intracellular signaling via the CD3 complex and ZAP-70 kinase to activate the CD4+ T cell (Janeway et al., 2001; Avci et al., 2011).